help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giagulli, V. A.
Right arrow Articles by Vermeulen, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giagulli, V. A.
Right arrow Articles by Vermeulen, A.

Journal of Clinical Endocrinology & Metabolism, Vol 76, 429-431, Copyright © 1993 by Endocrine Society

ARTICLES

Comparison of plasma androgen glucuronide levels after percutaneous or peroral androgen treatment in men: evidence for important splanchnic contribution to plasma 17 beta-hydroxyandrogen glucuronides

VA Giagulli, L Verdonck, JP Deslypere, R Giorgino and A Vermeulen
Department of Endocrinology, University Hospital, Ghent, Belgium.

To investigate whether glucuronides of 17 beta-hydroxyandrogens are formed mainly in peripheral tissues or in splanchnic tissues, we compared androstanediol (AD) glucuronide (ADG) and dihydrotestosterone (DHT) glucuronide (DHTG) levels as well as the ratios of glucuronides over free steroids after transcutaneous DHT gel administration to levels and ratios found after oral administration of testosterone undecanoate. Whereas DHT and AD plasma levels were much higher after transcutaneous DHT gel administration, ADG and DHTG levels as well as glucuronide/free androgen ratios were an order of a magnitude higher after oral TU. This indicates that 17 beta-hydroxyandrogen glucuronides cannot be considered specific metabolites of androgen target tissues and are formed to a large extent in the splanchnic circulation.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
B. Z. Leder, D. H. Catlin, C. Longcope, B. Ahrens, D. A. Schoenfeld, and J. S. Finkelstein
Metabolism of Orally Administered Androstenedione in Young Men
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3654 - 3658.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S.-H. Peng, J. Segura, M. Farre, and X. de la Torre
Oral Testosterone Administration Detected by Testosterone Glucuronidation Measured in Blood Spots Dried on Filter Paper
Clin. Chem., April 1, 2000; 46(4): 515 - 522.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. C. Pirog and D. C. Collins
Metabolism of Dihydrotestosterone in Human Liver: Importance of 3{alpha}- and 3{beta}-Hydroxysteroid Dehydrogenase
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3217 - 3221.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society